Arbutus Biopharma (ABUS) Operating Expenses (2013 - 2026)
Arbutus Biopharma (ABUS) posted Operating Expenses of $10.2 million for Q1 2026, up 61.14% sequentially from $6.3 million in Q4 2025, and down 62.79% YoY from $27.5 million in Q1 2025.
Arbutus Biopharma (ABUS) Operating Expenses (2013 - 2026) Analysis & Trends
Arbutus Biopharma has reported Operating Expenses for 14 years, with the latest figure at $10.2 million in Q1 2026.
- Quarterly Operating Expenses fell 62.79% year-over-year to $10.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $35.0 million (down 60.7% YoY) and the FY2025 annual result came in at $52.2 million, down 36.67% from the prior year.
- Operating Expenses advanced to $10.2 million in Q1 2026 per ABUS's latest filing, from $6.3 million in the prior quarter.
- Over five years, Operating Expenses peaked at $28.8 million in Q4 2022 and troughed at $6.3 million in Q4 2025.
- A 5-year average of $20.3 million and a median of $23.0 million in 2023 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2022 and 2026: Operating Expenses jumped 35.19% in 2022, then sank 62.79% in 2026.
- Over 5 years, Operating Expenses stood at $28.8 million in 2022, then decreased by 20.53% to $22.9 million in 2023, then slumped by 32.26% to $15.5 million in 2024, then plunged by 59.11% to $6.3 million in 2025, then jumped by 61.14% to $10.2 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $10.2 million, $6.3 million, and $9.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Arbutus Biopharma | 922.95 Mn | 830.33 Mn | - | 6.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.98 Mn |
| Mar 31, 2026 | 10.22 Mn |
| Dec 31, 2025 | 6.34 Mn |
| Sep 30, 2025 | 9.19 Mn |
| Jun 30, 2025 | 9.25 Mn |
| Mar 31, 2025 | 27.46 Mn |
| Dec 31, 2024 | 15.51 Mn |
| Sep 30, 2024 | 22.78 Mn |
| Jun 30, 2024 | 23.31 Mn |
| Mar 31, 2024 | 20.90 Mn |
| Dec 31, 2023 | 22.89 Mn |
| Sep 30, 2023 | 26.22 Mn |
| Jun 30, 2023 | 23.04 Mn |
| Mar 31, 2023 | 24.10 Mn |
| Dec 31, 2022 | 28.81 Mn |
| Sep 30, 2022 | 23.76 Mn |
| Jun 30, 2022 | 28.35 Mn |
| Mar 31, 2022 | 23.56 Mn |
| Dec 31, 2021 | 24.00 Mn |
| Sep 30, 2021 | 21.75 Mn |